Amount Raised
$15 Million
Round Type
Funding Round
HoustonManufacturingDescription
Mission Therapeutics (“Mission”), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), today announced that it has raised $15m (£12m) in equity investment. The round was led by existing investor Pfizer Ventures, the venture capital arm of Pfizer Inc. (“Pfizer”)(NYSE: PFE).
Who else raised in Manufacturing around the same time
Companies in the same sectors as Mission Therapeutics Limited that raised within 45 days of this round, from Fundz verified event records.
- NALA Membranes raised $2.1M (Seed) on August 20, 2020.
- Revolution Gelato, Inc. raised $180K (Pre-Seed) on August 20, 2020.
- Arevo, Inc. raised $19M on August 19, 2020.
- Mixlab raised $2M (Seed) on August 18, 2020.
- Battery Grade Materials, Inc. raised $300K (Seed) on August 18, 2020.
- Vessl, Inc. raised $3M (Seed) on August 18, 2020.
Who to call at Mission Therapeutics Limited, and when
A new round usually means Mission Therapeutics Limited is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Mission Therapeutics Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mission Therapeutics Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mission Therapeutics Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mission Therapeutics Limited raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Mission Therapeutics Limited raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.